Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Oestrogens conjugated
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Premarin 0.625mg tablets
0604011P0BBAAAB
|
Premarin (Systemic) | Oestrogens conjugated | Endocrine System | 15,417 |
|
Premarin 1.25mg tablets
0604011P0BBABAC
|
Premarin (Systemic) | Oestrogens conjugated | Endocrine System | 8,913 |
|
Conjugated oestrogens 625microgram tablets
0604011P0AAABAB
|
Oestro Conj (Systemic) | Oestrogens conjugated | Endocrine System | 6,787 |
|
Premarin 0.3mg tablets
0604011P0BBAGAF
|
Premarin (Systemic) | Oestrogens conjugated | Endocrine System | 4,632 |
|
Conjugated oestrogens 1.25mg tablets
0604011P0AAACAC
|
Oestro Conj (Systemic) | Oestrogens conjugated | Endocrine System | 3,836 |
|
Conjugated oestrogens 300microgram tablets
0604011P0AAAFAF
|
Oestro Conj (Systemic) | Oestrogens conjugated | Endocrine System | 1,888 |
|
Premarin 0.625mg/g vaginal cream
0702010I0BBAAAA
|
Premarin (Vaginal) | Oestrogens conjugated | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
|
Conjugated oestrogens 2.5mg tablets
0604011P0AAADAD
|
Oestro Conj (Systemic) | Oestrogens conjugated | Endocrine System | No data available |
|
Conjugated oestrogens 625micrograms/g vaginal cream
0702010I0AAAAAA
|
Oestro Conj (Vaginal) | Oestrogens conjugated | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Premarin 2.5mg tablets
0604011P0BBACAD
|
Premarin (Systemic) | Oestrogens conjugated | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.